The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Tumor‐associated macrophages in liver cancer: From mechanisms to therapy
Open accessAbstract
Multidimensional analyses have demonstrated the presence of a unique tumor microenvironment (TME) in liver cancer. Tumor‐associated macrophages (TAMs) are among the most abundant immune cells infiltrating the TME and are present at all stages of liver cancer progression, and targeting TAMs has become one of the most favored immunotherapy strategies. In addition, macrophages and liver cancer cells have distinct origins. At the early stage of liver cancer, macrophages can provide a niche for the maintenance of liver cancer stem cells. In contrast, cancer stem cells (CSCs) or poorly differentiated tumor cells are key factors modulating macrophage activation. In the present review, we first propose the origin connection between precursor macrophages and liver cancer cells. Macrophages undergo dynamic phenotypic transition during carcinogenesis. In this course of such transition, it is critical to determine the appropriate timing for therapy and block specific markers to suppress pro‐tumoral TAMs. The present review provides a more detailed discussion of transition trends of such surface markers than previous reviews. Complex crosstalk occurs between TAMs and liver cancer cells. TAMs play indispensable roles in tumor progression, angiogenesis, and autophagy due to their heterogeneity and robust plasticity. In addition, macrophages in the TME interact with other immune cells by directing cell‐to‐cell contact or secreting various effector molecules. Similarly, tumor cells combined with other immune cells can drive macrophage recruitment and polarization. Despite the latest achievements and the advancements in treatment strategies following TAMs studies, comprehensive discussions on the communication between macrophages and cancer cells or immune cells in liver cancer are currently lacking. In this review, we discussed the interactions between TAMs and liver cancer cells (from cell origin to maturation), the latest therapeutic strategies (including chimeric antigen receptor macrophages), and critical clinical trials for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (iCCA) to provide a rationale for further clinical investigation of TAMs as a potential target for treating patients with liver cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib
Kudo, M. (2017) · Liver Cancer · doi:10.1159/000462153 · Cited by 5,936
Macrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684
Tumour-associated macrophages as treatment targets in oncology
Mantovani, A., Marchesi, F., Malesci, A., Laghi, L., & Allavena, P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.217 · Cited by 4,033
Bruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Andtbacka, R. H. I., Kaufman, H. L., Collichio, F., Amatruda, T., Senzer, N., Chesney, J., Delman, K. A., Spitler, L. E., Puzanov, I., Agarwala, S. S., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3377 · Cited by 2,634
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Gomez Perdiguero, E., Klapproth, K., Schulz, C., Busch, K., Azzoni, E., Crozet, L., Garner, H., Trouillet, C., de Bruijn, M. F., Geissmann, F., et al. (2015) · Nature · doi:10.1038/nature13989 · Cited by 2,339 · cited 1×
“Therefore, unraveling the mystery of this heterogeneity is essential for targetedmacrophage therapy [27, 28] (Figure 2).”
BackgroundSingle-Cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment
Azizi, E., Carr, A. J., Plitas, G., Cornish, A. E., Konopacki, C., Prabhakaran, S., Nainys, J., Wu, K., Kiseliovas, V., Setty, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.05.060 · Cited by 1,976
Macrophages and metabolism in the tumor microenvironment
Vitale, I., Manic, G., Coussens, L. M., Kroemer, G., & Galluzzi, L. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.001 · Cited by 1,837
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Rőszer, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/816460 · Cited by 1,762
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Zhang, Q., He, Y., Luo, N., Patel, S. J., Han, Y., Gao, R., Modak, M., Carotta, S., Haslinger, C., Kind, D., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.003 · Cited by 1,624
CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis
Jaiswal, S., Jamieson, C. H. M., Pang, W. W., Park, C. Y., Chao, M. P., Majeti, R., Traver, D., van Rooijen, N., & Weissman, I. L. (2009) · Cell · doi:10.1016/j.cell.2009.05.046 · Cited by 1,581
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
MacParland, S. A., Liu, J. C., Ma, X.-Z., Innes, B. T., Bartczak, A. M., Gage, B. K., Manuel, J., Khuu, N., Echeverri, J., Linares, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06318-7 · Cited by 1,552
Human chimeric antigen receptor macrophages for cancer immunotherapy
Klichinsky, M., Ruella, M., Shestova, O., Lu, X. M., Best, A., Zeeman, M., Schmierer, M., Gabrusiewicz, K., Anderson, N. R., Petty, N. E., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0462-y · Cited by 1,495
Liver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Hiam-Galvez, K. J., Allen, B. M., & Spitzer, M. H. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00347-z · Cited by 1,400
IFNγ: signalling, epigenetics and roles in immunity, metabolism, disease and cancer immunotherapy
Ivashkiv, L. B. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0029-z · Cited by 1,358
Bain, C. C., Bravo-Blas, A., Scott, C. L., Gomez Perdiguero, E., Geissmann, F., Henri, S., Malissen, B., Osborne, L. C., Artis, D., & Mowat, A. M. (2014) · Nature Immunology · doi:10.1038/ni.2967 · Cited by 1,178
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Sia, D., Villanueva, A., Friedman, S. L., & Llovet, J. M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.048 · Cited by 1,153
A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells
Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D. R., Cumano, A., & Geissmann, F. (2006) · Science · doi:10.1126/science.1117729 · Cited by 1,053
Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination
Yu, J., Green, M. D., Li, S., Sun, Y., Journey, S. N., Choi, J. E., Rizvi, S. M., Qin, A., Waninger, J. J., Lang, X., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-1131-x · Cited by 1,001
Targeting tumor-associated macrophages to synergize tumor immunotherapy
Xiang, X., Wang, J., Lu, D., & Xu, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00484-9 · Cited by 966
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Xia, Y., Rao, L., Yao, H., Wang, Z., Ning, P., & Chen, X. (2020) · Advanced Materials · doi:10.1002/adma.202002054 · Cited by 949
Cassetta, L., Fragkogianni, S., Sims, A. H., Swierczak, A., Forrester, L. M., Zhang, H., Soong, D. Y. H., Cotechini, T., Anur, P., Lin, E. Y., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.02.009 · Cited by 920
Specification of tissue-resident macrophages during organogenesis
Mass, E., Ballesteros, I., Farlik, M., Halbritter, F., Günther, P., Crozet, L., Jacome-Galarza, C. E., Händler, K., Klughammer, J., Kobayashi, Y., et al. (2016) · Science · doi:10.1126/science.aaf4238 · Cited by 891
Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells
Scott, C. L., Zheng, F., De Baetselier, P., Martens, L., Saeys, Y., De Prijck, S., Lippens, S., Abels, C., Schoonooghe, S., Raes, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms10321 · Cited by 860
Zhou, S.-L., Zhou, Z.-J., Hu, Z.-Q., Huang, X.-W., Wang, Z., Chen, E.-B., Fan, J., Cao, Y., Dai, Z., & Zhou, J. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.040 · Cited by 852
CSF-1 receptor signaling in myeloid cells.
Stanley, E. R., & Chitu, V. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021857 · Cited by 825
Hezaveh, K., Shinde, R. S., Klötgen, A., Halaby, M. J., Lamorte, S., Ciudad, M. T., Quevedo, R., Neufeld, L., Liu, Z. Q., Jin, R., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.01.006 · Cited by 746
Li, X., Yao, W., Yuan, Y., Chen, P., Li, B., Li, J., Chu, R., Song, H., Xie, D., Jiang, X., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-310514 · Cited by 737
Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., & Brooks, A. G. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.5.813 · Cited by 727
Pombo Antunes, A. R., Scheyltjens, I., Lodi, F., Messiaen, J., Antoranz, A., Duerinck, J., Kancheva, D., Martens, L., De Vlaminck, K., Van Hove, H., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00789-y · Cited by 704
Wen, Y., Lambrecht, J., Ju, C., & Tacke, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00558-8 · Cited by 695
Origins of tumor-associated macrophages and neutrophils
Cortez-Retamozo, V., Etzrodt, M., Newton, A., Rauch, P. J., Chudnovskiy, A., Berger, C., Ryan, R. J. H., Iwamoto, Y., Marinelli, B., Gorbatov, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113744109 · Cited by 689
Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease
Mulder, K., Patel, A. A., Kong, W. T., Piot, C., Halitzki, E., Dunsmore, G., Khalilnezhad, S., Irac, S. E., Dubuisson, A., Chevrier, M., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.07.007 · Cited by 678
Sharma, A., Seow, J. J. W., Dutertre, C.-A., Pai, R., Blériot, C., Mishra, A., Wong, R. M. M., Singh, G. S. N., Sudhagar, S., Khalilnezhad, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.040 · Cited by 677
Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D. M., Zou, W., & Welling, T. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.039 · Cited by 675
Huang, S. C.-C., Smith, A. M., Everts, B., Colonna, M., Pearce, E. L., Schilling, J. D., & Pearce, E. J. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.016 · Cited by 667
Macrophage phenotypes in atherosclerosis
Colin, S., Chinetti‐Gbaguidi, G., & Staels, B. (2014) · Immunological Reviews · doi:10.1111/imr.12218 · Cited by 657
Tissue‐resident macrophages provide a pro‐tumorigenic niche to early NSCLC cells
Casanova-Acebes, M., Dalla, E., Leader, A. M., LeBerichel, J., Nikolic, J., Morales, B. M., Brown, M., Chang, C., Troncoso, L., Chen, S. T., et al. (2021) · Nature · doi:10.1038/s41586-021-03651-8 · Cited by 629
Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer
Nalio Ramos, R., Missolo-Koussou, Y., Gerber-Ferder, Y., Bromley, C. P., Bugatti, M., Núñez, N. G., Tosello Boari, J., Richer, W., Menger, L., Denizeau, J., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.021 · Cited by 583
Ju, C., & Tacke, F. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.104 · Cited by 554
Yang, P., Li, Q.-J., Feng, Y., Zhang, Y., Markowitz, G. J., Ning, S., Deng, Y., Zhao, J., Jiang, S., Yuan, Y., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.07.023 · Cited by 536
Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinoma
Cheng, A.-L., Hsu, C., Chan, S. L., Choo, S.-P., & Kudo, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.025 · Cited by 528
Macrophage Metabolism Controls Tumor Blood Vessel Morphogenesis and Metastasis
Wenes, M., Shang, M., Di Matteo, M., Goveia, J., Martín-Pérez, R., Serneels, J., Prenen, H., Ghesquière, B., Carmeliet, P., & Mazzone, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.008 · Cited by 496
Gunassekaran, G. R., Poongkavithai Vadevoo, S. M., Baek, M.-C., & Lee, B. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121137 · Cited by 483
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Tavazoie, M. F., Pollack, I., Tanqueco, R., Ostendorf, B. N., Reis, B. S., Gonsalves, F. C., Kurth, I., Andreu-Agullo, C., Derbyshire, M. L., Posada, J., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.026 · Cited by 476
Deciphering human macrophage development at single-cell resolution
Bian, Z., Gong, Y., Huang, T., Lee, C. Z. W., Bian, L., Bai, Z., Shi, H., Zeng, Y., Liu, C., He, J., et al. (2020) · Nature · doi:10.1038/s41586-020-2316-7 · Cited by 467
Cell tracing shows the contribution of the yolk sac to adult haematopoiesis
Samokhvalov, I. M., Samokhvalova, N. I., & Nishikawa, S.-I. (2007) · Nature · doi:10.1038/nature05725 · Cited by 460
Kato, Y., Tabata, K., Kimura, T., Yachie-Kinoshita, A., Ozawa, Y., Yamada, K., Ito, J., Tachino, S., Hori, Y., Matsuki, M., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212513 · Cited by 460
Fan, Q.-M., Jing, Y.-Y., Yu, G.-F., Kou, X.-R., Ye, F., Gao, L., Li, R., Zhao, Q.-D., Yang, Y., Lu, Z.-H., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.05.008 · Cited by 458
Yeung, O. W. H., Lo, C.-M., Ling, C.-C., Qi, X., Geng, W., Li, C.-X., Ng, K. T. P., Forbes, S. J., Guan, X.-Y., Poon, R. T. P., et al. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.029 · Cited by 453
Zhu, Y., Yang, J., Xu, D., Gao, X.-M., Zhang, Z., Hsu, J. L., Li, C.-W., Lim, S.-O., Sheng, Y.-Y., Zhang, Y., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318419 · Cited by 419
Glycolytic Stimulation Is Not a Requirement for M2 Macrophage Differentiation
Wang, F., Zhang, S., Vuckovic, I., Jeon, R., Lerman, A., Folmes, C. D., Dzeja, P. P., & Herrmann, J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.012 · Cited by 415
Zhou, J., Li, X., Wu, X., Zhang, T., Zhu, Q., Wang, X., Wang, H., Wang, K., Lin, Y., & Wang, X. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0479 · Cited by 386
Zhang, W., Zhu, X.-D., Sun, H.-C., Xiong, Y.-Q., Zhuang, P.-Y., Xu, H.-X., Kong, L.-Q., Wang, L., Wu, W.-Z., & Tang, Z.-Y. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2904 · Cited by 374
Self-citationLoeuillard, E., Yang, J., Buckarma, E., Wang, J., Liu, Y., Conboy, C., Pavelko, K. D., Li, Y., O’Brien, D., Wang, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137110 · Cited by 369
Liu, C., Chikina, M., Deshpande, R., Menk, A. V., Wang, T., Tabib, T., Brunazzi, E. A., Vignali, K. M., Sun, M., Stolz, D. B., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.017 · Cited by 345
Boosting anti-PD-1 therapy with metformin-loaded macrophage-derived microparticles
Wei, Z., Zhang, X., Yong, T., Bie, N., Zhan, G., Li, X., Liang, Q., Li, J., Yu, J., Huang, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20723-x · Cited by 342
Self-citationPark, J.-S., Kim, I.-K., Han, S., Park, I., Kim, C., Bae, J., Oh, S. J., Lee, S., Kim, J. H., Woo, D.-C., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.018 · Cited by 327
Zhang, W., Liu, L., Su, H., Liu, Q., Shen, J., Dai, H., Zheng, W., Lu, Y., Zhang, W., Bei, Y., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0578-3 · Cited by 291
Self-citationPetty, A. J., Li, A., Wang, X., Dai, R., Heyman, B., Hsu, D., Huang, X., & Yang, Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128644 · Cited by 287
Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
Asgharzadeh, S., Salo, J. A., Ji, L., Oberthuer, A., Fischer, M., Berthold, F., Hadjidaniel, M., Liu, C. W.-Y., Metelitsa, L. S., Pique-Regi, R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.9169 · Cited by 285
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
Boulter, L., Guest, R. V., Kendall, T. J., Wilson, D. H., Wojtacha, D., Robson, A. J., Ridgway, R. A., Samuel, K., Van Rooijen, N., Barry, S. T., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76452 · Cited by 278
Dong, L., Chen, C., Zhang, Y., Guo, P., Wang, Z., Li, J., Liu, Y., Liu, J., Chang, R., Li, Y., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.04.016 · Cited by 278
Nebbia, G., Peppa, D., Schurich, A., Khanna, P., Singh, H. D., Cheng, Y., Rosenberg, W., Dusheiko, G., Gilson, R., ChinAleong, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047648 · Cited by 276
Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
Hasita, H., Komohara, Y., Okabe, H., Masuda, T., Ohnishi, K., Lei, X. F., Beppu, T., Baba, H., & Takeya, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01614.x · Cited by 275
Regulation of Macrophage Activation and Polarization by HCC-Derived Exosomal lncRNA TUC339
Li, X., Lei, Y., Wu, M., & Li, N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19102958 · Cited by 272
RIPK3 Orchestrates Fatty Acid Metabolism in Tumor-Associated Macrophages and Hepatocarcinogenesis
Wu, L., Zhang, X., Zheng, L., Zhao, H., Yan, G., Zhang, Q., Zhou, Y., Lei, J., Zhang, J., Wang, J., et al. (2020) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-19-0261 · Cited by 272
Wu, Q., Zhou, W., Yin, S., Zhou, Y., Chen, T., Qian, J., Su, R., Hong, L., Lu, H., Zhang, F., et al. (2019) · Hepatology · doi:10.1002/hep.30593 · Cited by 269
Wehr, A., Baeck, C., Heymann, F., Niemietz, P. M., Hammerich, L., Martin, C., Zimmermann, H. W., Pack, O., Gassler, N., Hittatiya, K., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202909 · Cited by 268
Activating a collaborative innate-adaptive immune response to control metastasis
Sun, L., Kees, T., Almeida, A. S., Liu, B., He, X.-Y., Ng, D., Han, X., Spector, D. L., McNeish, I. A., Gimotty, P., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.08.005 · Cited by 267
Tie2-Expressing Monocytes and Tumor Angiogenesis: Regulation by Hypoxia and Angiopoietin-2
Lewis, C. E., De Palma, M., & Naldini, L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1684 · Cited by 261
Hou, P.-P., Luo, L.-J., Chen, H.-Z., Chen, Q.-T., Bian, X.-L., Wu, S.-F., Zhou, J.-X., Zhao, W.-X., Liu, J.-M., Wang, X.-M., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.05.004 · Cited by 253
MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation
Aucher, A., Rudnicka, D., & Davis, D. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301728 · Cited by 247
Molecular Pathogenesis and Targeted Therapies for Intrahepatic Cholangiocarcinoma
Moeini, A., Sia, D., Bardeesy, N., Mazzaferro, V., & Llovet, J. M. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-3296 · Cited by 240
Ontogeny of Tumor-Associated Macrophages
Laviron, M., & Boissonnas, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01799 · Cited by 239
Bao, D., Zhao, J., Zhou, X., Yang, Q., Chen, Y., Zhu, J., Yuan, P., Yang, J., Qin, T., Wan, S., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0772-z · Cited by 235
Self-citationLa Fleur, L., Botling, J., He, F., Pelicano, C., Zhou, C., He, C., Palano, G., Mezheyeuski, A., Micke, P., Ravetch, J. V., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1885 · Cited by 224
Hage, C., Hoves, S., Strauss, L., Bissinger, S., Prinz, Y., Pöschinger, T., Kiessling, F., & Ries, C. H. (2019) · Hepatology · doi:10.1002/hep.30666 · Cited by 221
Kang, M., Lee, S. H., Kwon, M., Byun, J., Kim, D., Kim, C., Koo, S., Kwon, S. P., Moon, S., Jung, M., et al. (2021) · Advanced Materials · doi:10.1002/adma.202103258 · Cited by 219
Ambade, A., Lowe, P., Kodys, K., Catalano, D., Gyongyosi, B., Cho, Y., Iracheta‐Vellve, A., Adejumo, A., Saha, B., Calenda, C., et al. (2019) · Hepatology · doi:10.1002/hep.30249 · Cited by 214
Yuan, D., Huang, S., Berger, E., Liu, L., Gross, N., Heinzmann, F., Ringelhan, M., Connor, T. O., Stadler, M., Meister, M., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.05.006 · Cited by 197
Anti–PD-L1 Treatment Results in Functional Remodeling of the Macrophage Compartment
Xiong, H., Mittman, S., Rodriguez, R., Moskalenko, M., Pacheco-Sanchez, P., Yang, Y., Nickles, D., & Cubas, R. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3208 · Cited by 197
M1 Macrophages Induce PD-L1 Expression in Hepatocellular Carcinoma Cells Through IL-1β Signaling
Zong, Z., Zou, J., Mao, R., Ma, C., Li, N., Wang, J., Wang, X., Zhou, H., Zhang, L., & Shi, Y. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01643 · Cited by 196
Chen, J., Lin, Z., Liu, L., Zhang, R., Geng, Y., Fan, M., Zhu, W., Lu, M., Lu, L., Jia, H., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00784-0 · Cited by 195
Kuipers, H., Muskens, F., Willart, M., Hijdra, D., van Assema, F. B. J., Coyle, A. J., Hoogsteden, H. C., & Lambrecht, B. N. (2006) · European Journal of Immunology · doi:10.1002/eji.200635978 · Cited by 191
Loss of SIRT5 promotes bile acid-induced immunosuppressive microenvironment and hepatocarcinogenesis
Sun, R., Zhang, Z., Bao, R., Guo, X., Gu, Y., Yang, W., Wei, J., Chen, X., Tong, L., Meng, J., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.02.030 · Cited by 184
Adachi, Y., Kamiyama, H., Ichikawa, K., Fukushima, S., Ozawa, Y., Yamaguchi, S., Goda, S., Kimura, T., Kodama, K., Matsuki, M., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2426 · Cited by 181
Yin, C., Han, Q., Xu, D., Zheng, B., Zhao, X., & Zhang, J. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1601479 · Cited by 178
He, Q., Liu, M., Huang, W., Chen, X., Zhang, B., Zhang, T., Wang, Y., Liu, D., Xie, M., Ji, X., et al. (2021) · Hepatology · doi:10.1002/hep.32062 · Cited by 177
Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes
Shand, F. H. W., Ueha, S., Otsuji, M., Koid, S. S., Shichino, S., Tsukui, T., Kosugi-Kanaya, M., Abe, J., Tomura, M., Ziogas, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402914111 · Cited by 175
Ontogeny of Tumor-Associated Macrophages and Its Implication in Cancer Regulation
Franklin, R. A., & Li, M. O. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2015.11.004 · Cited by 175
Early hematopoiesis and macrophage development
McGrath, K. E., Frame, J. M., & Palis, J. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2016.03.013 · Cited by 174
Raggi, C., Correnti, M., Sica, A., Andersen, J. B., Cardinale, V., Alvaro, D., Chiorino, G., Forti, E., Glaser, S., Alpini, G., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.012 · Cited by 172
Ao, J.-Y., Zhu, X.-D., Chai, Z.-T., Cai, H., Zhang, Y.-Y., Zhang, K.-Z., Kong, L.-Q., Zhang, N., Ye, B.-G., Ma, D.-N., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0866 · Cited by 171
Chen, D.-P., Ning, W.-R., Jiang, Z.-Z., Peng, Z.-P., Zhu, L.-Y., Zhuang, S.-M., Kuang, D.-M., Zheng, L., & Wu, Y. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.04.007 · Cited by 170
Sprinzl, M. F., Reisinger, F., Puschnik, A., Ringelhan, M., Ackermann, K., Hartmann, D., Schiemann, M., Weinmann, A., Galle, P. R., Schuchmann, M., et al. (2013) · Hepatology · doi:10.1002/hep.26328 · Cited by 169
New Angiogenic Regulators Produced by TAMs: Perspective for Targeting Tumor Angiogenesis
Larionova, I., Kazakova, E., Gerashchenko, T., & Kzhyshkowska, J. (2021) · Cancers · doi:10.3390/cancers13133253 · Cited by 166
Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma
Xiao, Z., Chung, H., Banan, B., Manning, P. T., Ott, K. C., Lin, S., Capoccia, B. J., Subramanian, V., Hiebsch, R. R., Upadhya, G. A., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.036 · Cited by 164
Tan, H.-Y., Wang, N., Man, K., Tsao, S., Che, C., & Feng, Y. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.271 · Cited by 162
Wei, C., Zhu, M.-X., Zhang, P., Huang, X., Wan, J., Yao, X., Hu, Z.-T., Chai, X., Peng, R., Yang, X., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.02.019 · Cited by 162
Self-citationZhang, Y.-L., Li, Q., Yang, X.-M., Fang, F., Li, J., Wang, Y.-H., Yang, Q., Zhu, L., Nie, H.-Z., Zhang, X.-L., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2867 · Cited by 160
Self-citationPrimordial GATA6 macrophages function as extravascular platelets in sterile injury
Zindel, J., Peiseler, M., Hossain, M., Deppermann, C., Lee, W., Haenni, B., Zuber, B., Deniset, J., Surewaard, B. G. J., Candinas, D., et al. (2021) · Science · doi:10.1126/science.abe0595 · Cited by 160
Simone, G. D., Andreata, F., Blériot, C., Fumagalli, V., Laura, C., García-Manteiga, J. M., Lucia, P. D., Gilotto, S., Ficht, X., Ponti, F. F. D., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.05.005 · Cited by 160
Yao, W., Ba, Q., Li, X., Li, H., Zhang, S., Yuan, Y., Wang, F., Duan, X., Li, J., Zhang, W., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.07.014 · Cited by 156
Self-citationYu, J., Han, Q., Zhao, H., & Zhang, J. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01808-3 · Cited by 153
Zhou, Z., Wang, P., Sun, R., Li, J., Hu, Z., Xin, H., Luo, C., Zhou, J., Fan, J., & Zhou, S. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001946 · Cited by 153
Ou, D., Chen, C.-W., Hsu, C., Chung, C., Feng, Z.-R., Lee, B.-S., Cheng, A., Yang, M., & Hsu, C. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001657 · Cited by 152
Diggs, L. P., Ruf, B., Ma, C., Heinrich, B., Cui, L., Zhang, Q., McVey, J. C., Wabitsch, S., Heinrich, S., Rosato, U., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.037 · Cited by 151
Liu, Y., Zhao, L., Li, D., Yin, Y., Zhang, C., Li, J., & Zhang, Y. (2013) · Protein & Cell · doi:10.1007/s13238-013-3092-z · Cited by 143
Matsubara, T., Kanto, T., Kuroda, S., Yoshio, S., Higashitani, K., Kakita, N., Miyazaki, M., Sakakibara, M., Hiramatsu, N., Kasahara, A., et al. (2012) · Hepatology · doi:10.1002/hep.25965 · Cited by 141
Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies
Quail, D. F., & Joyce, J. A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0133 · Cited by 137
Fu, X.-T., Song, K., Zhou, J., Shi, Y.-H., Liu, W.-R., Shi, G., Gao, Q., Wang, X.-Y., Ding, Z.-B., & Fan, J. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0771-8 · Cited by 137
Tumor-Derived Adenosine Promotes Macrophage Proliferation in Human Hepatocellular Carcinoma
Wang, J., Wang, Y., Chu, Y., Li, Z., Yu, X., Huang, Z., Xu, J., & Zheng, L. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.10.021 · Cited by 133
Chen, Y., Wong, P. P., Sjeklocha, L. M., Steer, C. J., & Sahin, B. M. (2011) · Hepatology · doi:10.1002/hep.24712 · Cited by 133
Chen, Y., Wen, H., Zhou, C., et al. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.03.005 · Cited by 129
Zhao, J., Li, H., Zhao, S., Wang, E., Zhu, J. W., Feng, D., Zhu, Y., Dou, W., Fan, Q., Hu, J., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01343-5 · Cited by 128
Self-citationCAR-macrophage: An extensive immune enhancer to fight cancer
Wang, S., Yang, Y., Ma, P., Zha, Y., Zhang, J., Lei, A., & Li, N. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103873 · Cited by 124
Immature hematopoietic stem cells undergo maturation in the fetal liver
Kieusseian, A., de la Grange, P. B., Burlen‐Defranoux, O., Godin, I., & Cumano, A. (2012) · Development · doi:10.1242/dev.079210 · Cited by 121
Yuan, W., Lao, X., Xiao, C., Wang, X., Wu, Z.-J., Zeng, Q., Wu, C.-Y., Wu, R., Chen, Z.-X., Zheng, L., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.250 · Cited by 120
Ye, Y., Guo, J., Xiao, P. G., Ning, J., Zhang, R., Liu, P., Yu, W., Xu, L., Zhao, Y. C., & Yu, J. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.001 · Cited by 118
Lu, L., Zhou, Z., Wang, X.-Y., Liu, B.-Y., Lu, J., Liu, S., Zhang, G., Zhan, M., & Chen, Y. (2022) · Gut · doi:10.1136/gutjnl-2021-326350 · Cited by 118
Lysyl Oxidase‐Like 4 Fosters an Immunosuppressive Microenvironment During Hepatocarcinogenesis
Tan, H., Wang, N., Zhang, C., Chan, Y.-T., Yuen, M., & Feng, Y. (2020) · Hepatology · doi:10.1002/hep.31600 · Cited by 116
Zhai, K., Huang, Z., Huang, Q., Tao, W., Fang, X., Zhang, A., Li, X., Stark, G. R., Hamilton, T. A., & Bao, S. (2021) · Nature Cancer · doi:10.1038/s43018-021-00267-9 · Cited by 115
Du, K., Li, Y., Liu, J., Chen, W., Wei, Z., Luo, Y., Liu, H., Qi, Y., Wang, F., & Sui, J. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.01.006 · Cited by 114
Circulating CD14+CD16+ monocyte levels predict tissue invasive character of cholangiocarcinoma
Subimerb, C., Pinlaor, S., Lulitanond, V, Khuntikeo, N., Okada, S., McGrath, M. S., & Wongkham, S. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04200.x · Cited by 113
Transdifferentiation of Mature Rat Hepatocytes into Bile Duct-Like Cells in Vitro
Nishikawa, Y., Doi, Y., Watanabe, H., Tokairin, T., Omori, Y., Su, M., Yoshioka, T., & Enomoto, K. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62328-0 · Cited by 113
Bartneck, M., Schrammen, P. L., Möckel, D., Govaere, O., Liepelt, A., Krenkel, O., Ergen, C., McCain, M. V., Eulberg, D., Luedde, T., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.10.007 · Cited by 112
Wang, Y., Wang, B., Xiao, S., Yang, L., & Chen, Q. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27436 · Cited by 110
Hou, Z., Xu, X., Fu, X., Zhou, L., Liu, S., & Tan, D. (2019) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00510.2018 · Cited by 110
Wang, Y., Gao, R., Li, J., Tang, S., Li, S., Tong, Q., & Li, S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s284560 · Cited by 109
Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment
Mahlbacher, G. E., Curtis, L. T., Lowengrub, J. S., & Frieboes, H. B. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0313-7 · Cited by 107
CD47 Blockade as an Adjuvant Immunotherapy for Resectable Pancreatic Cancer
Michaels, A. D., Newhook, T. E., Adair, S. J., Morioka, S., Goudreau, B. J., Nagdas, S., Mullen, M. G., Persily, J. B., Bullock, T. N. J., Slingluff, C. L., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2283 · Cited by 103
Hashimoto, A., Sarker, D., Reebye, V., Jarvis, S., Sodergren, M. H., Kossenkov, A. V., Sanseviero, E., Raulf, N., Vasara, J., Andrikakou, P., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0986 · Cited by 103
Ma, H., Kang, Z., Foo, T. K., Shen, Z., & Xia, B. (2022) · Hepatology · doi:10.1002/hep.32335 · Cited by 103
Individualized precision treatment: Targeting TAM in HCC
Li, Z., Wu, T., Zheng, B. J., & Chen, L. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.05.019 · Cited by 102
Macrophages facilitate resistance to anti-VEGF therapy by altered VEGFR expression
Dalton, H. J., Pradeep, S., McGuire, M., Hailemichael, Y., MA, S., Lyons, Y., Armaiz-Pena, G. N., Previs, R. A., Hansen, J. M., Rupaimoole, R., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0647 · Cited by 97
Chen, J., Zheng, D.-X., Yu, X.-J., Sun, H.-W., Xu, Y.-T., Zhang, Y., & Xu, J. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1652540 · Cited by 96
BACE inhibitors in clinical development for the treatment of Alzheimer’s disease
Panza, F., Lozupone, M., Solfrizzi, V., Sardone, R., Piccininni, C., Dibello, V., Stallone, R., Giannelli, G., Bellomo, A., Greco, A., et al. (2018) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1531706 · Cited by 92
Matrix stiffness‐mediated effects on macrophages polarization and their LOXL2 expression
Xing, X., Wang, Y., Zhang, X., Gao, X., Li, M., Wu, S., Zhao, Y., Chen, J., Gao, D., Chen, R., et al. (2021) · The FEBS Journal · doi:10.1111/febs.15566 · Cited by 92
Shiau, D.-J., Kuo, W., Davuluri, G. V. N., Shieh, C.-C. K., Tsai, P.-J., Chen, C., Lin, Y.-S., Wu, Y.-Z., Hsiao, Y.-P., & Chang, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-70137-4 · Cited by 91
Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma
Tanaka, S., Sugimachi, K., Yamashita, Y., Ohga, T., Shirabe, K., Shimada, M., Wands, J. R., & Sugimachi, K. (2002) · Hepatology · doi:10.1053/jhep.2002.32535 · Cited by 90
TWEAK/Fn14 signalling promotes cholangiocarcinoma niche formation and progression
Dwyer, B. J., Jarman, E. J., Gogoi-Tiwari, J., Ferreira-González, S., Boulter, L., Guest, R. V., Kendall, T. J., Kurian, D., Kilpatrick, A. M., Robson, A. J., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.018 · Cited by 90
APOBEC3B interaction with PRC2 modulates microenvironment to promote HCC progression
Wang, D., Li, X., Li, J., Lu, Y., Zhao, S., Tang, X., Chen, X., Li, J., Zheng, Y., Li, S., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317601 · Cited by 89
Xu, G., Feng, D., Yao, Y., Li, P., Sun, H., Yang, H., Li, C., Jiang, R., Sun, B., & Chen, Y. (2019) · Oncogene · doi:10.1038/s41388-019-1072-3 · Cited by 87
Liu, G., Ouyang, X., Sun, Y., Xiao, Y., You, B., Gao, Y., Yeh, S., Li, Y., & Chang, C. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0575-3 · Cited by 86
Vaeteewoottacharn, K., Kariya, R., Pothipan, P., Fujikawa, S., Pairojkul, C., Waraasawapati, S., Kuwahara, K., Wongkham, C., Wongkham, S., & Okada, S. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.10.007 · Cited by 84
Sprinzl, M. F., Puschnik, A. S., Schlitter, A. M., Schad, A., Ackermann, K., Esposito, I., Lang, H., Galle, P. R., Weinmann, A., Heikenwälder, M. F., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.011 · Cited by 82
Locatelli, S. L., Careddu, G., Serio, S., Consonni, F. M., Maeda, A., Viswanadha, S., Vakkalanka, S. V. S., Castagna, L., Santoro, A., Allavena, P., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1133 · Cited by 82
Yang, H. D., Kim, H. S., Kim, S. Y., Na, M. J., Yang, G., Eun, J. W., Wang, H.-J., Cheong, J. Y., Park, W. S., & Nam, S. W. (2019) · Hepatology · doi:10.1002/hep.30657 · Cited by 82
Zhu, F., Li, X., Chen, S., Zeng, Q., Zhao, Y., & Luo, F. (2016) · Medical Oncology · doi:10.1007/s12032-016-0729-9 · Cited by 78
Lo, J. H. T., Lau, E. Y.-T., So, F. T. Y., Lu, P., Chan, V. S. F., Cheung, V. C. H., Ching, R. H. H., Cheng, B. Y.-L., Ma, M. K. F., Ng, I. O., et al. (2015) · Liver International · doi:10.1111/liv.12963 · Cited by 77
Chen, M., Xiao, C., Lao, X., Yuan, W., Liu, R., Zeng, Q., Wang, J., Ouyang, F., Chen, D., Chan, K., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0329 · Cited by 76
MicroRNA-206 promotes the recruitment of CD8 + T cells by driving M1 polarisation of Kupffer cells
Liu, N., Wang, X., Steer, C. J., & Song, G. (2021) · Gut · doi:10.1136/gutjnl-2021-324170 · Cited by 76
Thompson, S. M., Wang, J., Chandan, V. S., Glaser, K. J., Roberts, L. R., Ehman, R. L., & Venkatesh, S. K. (2016) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2016.11.005 · Cited by 75
Wei, R., Zhu, W., Yu, G., Wang, X., Gao, C., Xu, Z., Lin, Z., Shao, W., Wang, S., Lü, M., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33371 · Cited by 73
Cantharidin Exerts Anti-Hepatocellular Carcinoma by Mir-214 Modulating Macrophage Polarization
Lu, S., Gao, Y., Huang, X., & Wang, X. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8002 · Cited by 71
Wang, L., Hu, Y., Zhao, J., Huang, F., Liang, S.-Q., Dong, L., Chen, Y., Yu, H., Bai, J., Yang, J., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000517 · Cited by 67
Yuan, H., Lin, Z., Liu, Y., Jiang, Y., Liu, K., Tu, M., Yao, N., Qu, C., & Hong, J. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01687-w · Cited by 67
Liu, D., Krummey, S. M., Badell, I. R., Wagener, M. E., Schneeweis, L. A., Stetsko, D. K., Suchard, S. J., Nadler, S. G., & Ford, M. L. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20130902 · Cited by 65
Wang, Q., Cheng, F., Ma, T., Xiong, H.-Y., Li, Z., Xie, C.-L., Liu, C., & Tu, Z. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2687-0 · Cited by 65
TIE-2 expressing monocytes in human cancers
Turrini, R., Pabois, A., Xénarios, I., Coukos, G., Delaloye, J.-F., & Doucey, M. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1303585 · Cited by 64
Yang, T., Deng, Z., Xu, L., Li, X., Tan, Y., Qian, Y., Lü, Y., Tian, L., Yao, W., & Wang, J. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02235-8 · Cited by 63
Sunakawa, Y., Stintzing, S., Cao, S., Heinemann, V., Cremolini, C., Falcone, A., Yang, D., Zhang, W., Ning, Y., Stremitzer, S., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv474 · Cited by 59
Self-citationGorrín-Rivas, M. J., Arii, S., Mori, A., Takeda, Y., Mizumoto, M., Furutani, M., & Imamura, M. (2000) · Annals of Surgery · doi:10.1097/00000658-200001000-00010 · Cited by 59
Sun, D., Luo, T., Dong, P., Zhang, N., Chen, J., Zhang, S., Dong, L., Janssen, H. L. A., & Zhang, S. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29514 · Cited by 58
Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma
Fernández‐Varo, G., Perramón, M., Carvajal, S., Oró, D., Casals, E., Boix, L., Oller, L., Macías‐Muñoz, L., Marfà, S., Casals, G., et al. (2020) · Hepatology · doi:10.1002/hep.31139 · Cited by 58
Zhang, W., Gong, C., Peng, X., Bi, X., Sun, Y., Zhou, J., Wu, F., Zeng, H., Wang, Y., Zhou, H., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-3972 · Cited by 54
Self-citationMao, J., Wang, D., Wang, Z., Tian, W., Li, X., Duan, J., Wang, Y., Yang, H., You, L., Cheng, Y., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.06.020 · Cited by 53
Zang, M., Li, Y., He, H., Ding, H., Chen, K., Du, J., Chen, T., Wu, Z., Liu, H., Wang, D., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.004 · Cited by 52
Bloemendaal, F. M., Koelink, P. J., van Schie, K. A., Rispens, T., Peters, C. P., Buskens, C. J., van der Bilt, J. D. W., Bemelman, W. A., Korf, H., Sabino, J., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy075 · Cited by 50
Li, L., Sun, P., Zhang, C., Li, Z., Cui, K., & Zhou, W. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0590-3 · Cited by 49
SIGLEC-3 (CD33) serves as an immune checkpoint receptor for HBV infection
Tsai, T., Huang, M.-T., Sung, P., Peng, C., Tao, M., Yang, H., Chang, W., Yang, A., Yu, C.-M., Lin, Y.-P., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141965 · Cited by 45
Li, L., Sun, P., Zhang, C., Li, Z., & Zhou, W. (2018) · Biochimie · doi:10.1016/j.biochi.2018.04.016 · Cited by 44
Liao, J., Zeng, D.-N., Li, J., Hua, Q., Huang, C., Xu, J., Wu, C., Zheng, L., Wen, W., & Wu, Y. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.09.021 · Cited by 44
Tumor‑associated macrophages recruited by periostin in intrahepatic cholangiocarcinoma stem cells
Zeng, J., Liu, Z., Sun, S., Xie, J., Cao, L., Lv, P., Nie, S., Zhang, B., Xie, B., Peng, S., et al. (2018) · Oncology Letters · doi:10.3892/ol.2018.8372 · Cited by 43
Zhou, B., Yang, Y., & Li, C. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s195234 · Cited by 41
Zhao, X., Wang, X., You, Y., Wen, D., Feng, Z., Zhou, Y., Que, K., Gong, J., & Liu, Z. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111979 · Cited by 40
3D micro-environment regulates NF-κβ dependent adhesion to induce monocyte differentiation
Bhattacharya, A., Agarwal, M., Mukherjee, R., Sen, P., & Sinha, D. K. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0993-z · Cited by 35
Li, G., & Zhao, L. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1642418 · Cited by 33
Zhou, B., Li, C., Yang, Y., & Wang, Z. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s258450 · Cited by 31
Fujita, N., Nishie, A., Aishima, S., Kubo, Y., Asayama, Y., Ishigami, K., Kakihara, D., Ushijima, Y., Takayama, Y., Shirabe, K., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3138 · Cited by 23
Dong, H., Xiang, S., Chen, X., Liang, H., Zhang, W., Jing, K., Zhang, W., Zhang, W., & Chen, L. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0321 · Cited by 19
Self-citationShibahara, J., Hayashi, A., Misumi, K., Sakamoto, Y., Arita, J., Hasegawa, K., Kokudo, N., & Fukayama, M. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000579 · Cited by 19
30th Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2015).
(2015) · PubMed · Cited by 6
Cited by
Exploring treatment options in cancer: tumor treatment strategies
Liu, B., Zhou, H., Tan, L., Siu, K. T. H., & Guan, X.-Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01856-7 · Cited by 1,201
The role of tumor-associated macrophages in tumor immune evasion
Huang, R., Kang, T., & Chen, S. (2024) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-024-05777-4 · Cited by 230
Liu, Y., Tang, Y., Jiang, H., Zhang, X., Chen, X., Guo, J., Jin, C., & Wu, M. (2023) · Biomolecules · doi:10.3390/biom14010041 · Cited by 19
Constructing biomimetic microenvironments for liver regeneration
(2025) · doi:10.1186/s12951-025-03729-9 · Cited by 11
Lian, Q., Ma, C., Wang, X., Wang, J., Zeng, J., Zhang, J., & Li, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1668627 · Cited by 10
Metadata
- Authors
- Cheng, K., Cai, N., Zhu, J., Yang, X., Liang, H., & Zhang, W.
- Venue
- Cancer Communications
- Published
- 2022-09-07
- Volume
- 42
- Issue
- 11
- Pages
- 1112-1140
- ISSN
- 1000-467X (ISSN-L)
- 2523-3548
- OpenAlex
- W4294921564
- Cited by
- 460
- References
- 186
- FWCI
- 26.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.